Common Stock, Shares, Issued of IVERIC bio, Inc. from 31 Dec 2012 to 31 Mar 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
IVERIC bio, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2012 to 31 Mar 2023.
  • IVERIC bio, Inc. Common Stock, Shares, Issued for the quarter ending 31 Mar 2023 was 137,249,579, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

IVERIC bio, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 137,249,579 +21,275,627 +18% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 136,639,687 +21,362,675 +19% 31 Dec 2022 10-Q 10 May 2023 2023 Q1
Q3 2022 120,572,641 +16,334,763 +16% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 116,874,198 +26,487,428 +29% 30 Jun 2022 10-Q 26 Jul 2022 2022 Q2
Q1 2022 115,973,952 +25,804,336 +29% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 115,277,012 +25,156,215 +28% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 104,237,878 +14,683,834 +16% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 90,386,770 +898,239 +1% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 90,169,616 +40,437,805 +81% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 90,120,797 +40,493,733 +82% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 89,554,044 +47,952,405 +115% 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 89,488,531 +48,011,111 +116% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 49,731,811 +8,278,741 +20% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 49,627,064 +8,229,867 +20% 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 41,601,639 +5,383,719 +15% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 41,477,420 +5,289,259 +15% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 41,453,070 +5,289,259 +15% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 41,397,197 +5,286,899 +15% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 36,217,920 +185,037 +0.51% 30 Sep 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 36,188,161 +255,982 +0.71% 30 Jun 2018 10-Q 01 Aug 2018 2018 Q2
Q1 2018 36,163,811 +343,422 +0.96% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 36,110,298 +377,022 +1.1% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 36,032,883 +383,582 +1.1% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 35,932,179 +421,235 +1.2% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 35,820,389 +530,254 +1.5% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 35,733,276 +536,709 +1.5% 31 Dec 2016 10-K 05 Mar 2018 2017 FY
Q3 2016 35,649,301 +745,420 +2.1% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 35,510,944 +835,540 +2.4% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 35,290,135 +1,044,405 +3% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 35,196,567 +1,202,047 +3.5% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 34,903,881 +1,317,272 +3.9% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 34,675,404 +1,223,396 +3.7% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 34,245,730 +920,964 +2.8% 31 Mar 2015 10-Q/A 28 Jul 2015 2015 Q1
Q4 2014 33,994,520 +2,581,312 +8.2% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q3 2014 33,586,609 +2,335,792 +7.5% 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 33,452,008 30 Jun 2014 10-Q 06 Aug 2014 2014 Q2
Q1 2014 33,324,766 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q4 2013 31,413,208 +29,943,410 +2037% 31 Dec 2013 10-K/A 28 Jul 2015 2014 FY
Q3 2013 31,250,817 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q4 2012 1,469,798 31 Dec 2012 10-K 11 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.